Vunakizumab Approved in China for Moderate-to-Severe Plaque Psoriasis
Vunakizumab, a new anti-IL-17A monoclonal antibody, is approved in China for adults with moderate-to-severe chronic plaque psoriasis after phase 3 ...
Tag: skin clearance
Three Years of Lebrikizumab Kept Atopic Dermatitis Controlled in Long-Term Extension Analysis
A post hoc analysis of week 16 responders from the ADvocate trials found that most maintained deep skin and itch ...
POPULAR NEWS
-
Springer Nature Launches Open-Access Journal Discover Pediatrics
-
Combined Cataract and Glaucoma Surgery Shows Strong One-Year Pressure Control
-
PBS-PBAT Blend Films Tune Strength, Moisture Barrier and UV Shielding for Biodegradable Packaging
-
Fruit Fly Eggshell Gene Reveals Purifying Selection with Episodes of Positive Evolution